Innovations & Research

January 24, 2014

Ron Cohen MD, President and Chief Executive Officer, Acorda Therapeutics, Inc., discusses what...

October 25, 2013

Stephan Tanda, Managing Board Member with Royal DSM, discusses what is necessary to create an...

December 11, 2012

President Obama signed the Jumpstart Our Business Startups (JOBS) Act into law on April 5,...

April 13, 2012

BIO President and CEO Jim Greenwood talks with Arnold Thackray, President and CEO of the Life...

Letters, Testimony & Comments

December 10 2014
A coalition of industry and university representatives, including BIO, submitted a letter to Chairman Goodlatte, Chairman Leahy, Rep. Conyers, and Senator Grassley address concerns related to harmful patent enforcement practices.
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of implementing policies that will spur job growth through capital formation while protecting investors.  
July 28 2011
BIO submitted testimony in support of USDA research funding to the House Agriculture Subcommittee on Rural Development, Research, Biotechnology, and Foreign Agriculture. Ag research programs within the USDA have sparked agricultural innovation and will help to solve the critical food and energy security challenges facing a rapidly growing global population.
January 11 2011
Public oral comments by David Edwards (BIO) to President's Council of Advisors on Science and Technology (PCAST) regarding the need to increase funding for agricultural research in research agencies and for extramural grants.
May 27 2009
The Biotechnology Industry Organization (BIO) thanks the National Institutes of Health (NIH) for the opportunity to submit comments on the draft guidelines for human stem cell research, published in the Federal Register on April 23, 2009...

Press Releases

February 9 2015
Report shows increase in funding for rare diseases and decrease in funding for chronic diseases
March 25 2014
Principles reaffirm and broaden biotech industry’s commitment to transparency, advancing research
March 5 2014
Many of the provisions included in this budget proposal would jeopardize the continued biotech research and development that is necessary to find cures and breakthrough medicines for patients living with debilitating and life-threatening diseases. 
July 10 2013
H.R. 2629 will cut compliance costs for innovative emerging biotech companies
April 8 2013
Strong Intellectual Property Protection Is Vital For The Life Sciences Industry.